The role of the NLRP3 inflammasome in gout
Sarah R Kingsbury1,2, Philip G Conaghan1,2, Michael F McDermott1,21Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine 2NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UKAbstract: Gout is an inflammatory ar...
Guardado en:
Autores principales: | Sarah R Kingsbury, Philip G Conaghan, Michael F McDermott |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22efc42338034d50a014abc4ebba21f8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
por: Ozaki E, et al.
Publicado: (2015) -
Spotlight on the NLRP3 inflammasome pathway
por: Groslambert M, et al.
Publicado: (2018) -
Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS)
por: Justin Gillespie, et al.
Publicado: (2010) -
New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease
por: Zhang J, et al.
Publicado: (2021) -
Resveratrol Relieves Gouty Arthritis by Promoting Mitophagy to Inhibit Activation of NLRP3 Inflammasomes
por: Fan W, et al.
Publicado: (2021)